tiprankstipranks
pc:hemos

HemostOD

HemostOD is a Swiss preclinical-stage healthcare company focused on developing a scalable and universal source of platelets produced ex vivo. Utilizing its proprietary bioreactor technology, HemostOD creates platelets in vitro from immortalized hematopoietic stem cells, eliminating the need for donors. This innovation aims to improve safety and availability, potentially transforming transfusion medicine by addressing the recurring shortages of platelets in medical care.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Seed Round
$4.30M

Investors

Investor Name
Funding Round

Related News and Analysis